JOFOC for Certara Phoenix Licenses

Awarded Limited / Sole Source Justification Posted

Solicitation number
75F40123Q00316
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
75F40123P00234 Federal contract award
Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

The U.S. Food and Drug Administration published a Limited/Sole Source Justification Notice on July 19, 2023 to award a sole source contract to Certara USA, Inc. for annual Phoenix Quantum software licenses. The FDA requires Phoenix Quantum to perform pharmacometrics reviews and analyses of clinical pharmacology and pharmacometrics data submitted in drug, biologics, veterinary medicines, and tobacco product applications to ensure safety and efficacy. Phoenix Quantum is cited as the only software that meets the FDA's requirements for such analyses. The contract was awarded to Certara USA, Inc. for an unknown quantity and value to provide Phoenix Quantum licenses and maintenance to allow FDA reviewers to complete regulatory duties.

Notice text

The objective is to obtain the annual Phoenix Quantum software licenses to allow OGD reviewers to complete the
review of ANDAs and well as other regulatory activities, such as pre-ANDA meeting package review and
production of product-specific bioequivalence guidance.

Awarded contract 75F40123P00234 to unknown vendor for unknown amount on 2023-07-19.

Files

File Type Posted
JOFOC.pdf PDF

Notice history

Notice Type Posted
This notice Latest Limited / Sole Source Justification
Certara Phoenix License Subscription Renewal Latest solicitation Solicitation
Notice of Intent for Sole Source - Certara Phoenix License Renewal Original Special Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors